Lateral Flow Assays: Characterizing Antibodies Using SPR Technology
Commercially available antibodies are typically poorly characterized and supplier statements on intended use are not necessarily reliable.
Surface plasmon resonance (SPR) technology is a label-free detection system that measures binding rates in real time, enabling you to select the best specific binding reagents for your lateral flow assays.
This webinar will review how kinetic characterization of biological interactions can guide the selection of best-in-class detector molecules to enhance lateral flow diagnostics and outline the benefits of characterizing and selecting your lateral flow antibodies using SPR technology.
Attend this webinar to:
- Critique current reagent selection strategies for lateral flow assays
- Learn more about the benefits of SPR
- Understand how kinetic characterization of biological interactions can guide selection of best-in-class detector molecules
- Review a case study on the selection of antibodies for the detection of a viral antigen in a lateral flow test
Presenter: Dr. Klaus Hochleitner (Global Lead Technical Product Specialist, Cytiva)
Presenter: Sarah Zachmann (Senior Diagnostic Scientist, Cytiva)
